Skip to content

The comparison between Promethazine and diazepam in the treatment of peripheral vertigo.

comparision of the effect of intervenous promethazine and diazepam on the reduction of peripheral true vertigo symptom s among the patients admited to the emergency ward

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016100530095N2
Enrollment
154
Registered
2016-11-18
Start date
2016-12-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The reduction of severity of peripheral true vertigo. Other peripheral vertigo

Interventions

Intervention 1: A) Type of intervention in the intervention group: The use of an injection of is promethazine (25mg) is dissolved in 100ml of normal-saline solution and infusion with in 20-30 minutes.
Treatment - Drugs
A) Type of intervention in the intervention group: The use of an injection of is promethazine (25mg) is dissolved in 100ml of normal-saline solution and infusion with in 20-30 minutes
B)Type of intervention in the control group:The use of an injection of diazepam (10mg) is dissolved in 100ml of normal-saline solution and infusion with in 20-30 minutes

Sponsors

Hormozgan university medical sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: inclusion criteria of study: patients admitted to Shahidmohammadi hospital with true vertigo? patients admitted to Shahidmohammadi hospital over 18 years old and less than 70 years old ? patients who do not intake anti-vertigo drugs before comming to hospital Exclusion criteria: pregnant women ? individuals who suffer from know drug"s allergy ? people who drink alcohol ? people who feel vertigo by using drugs ? people who seffer from advanced liver diseases ? patients who need to follow up with father checks ? people who do not cooperate in filling the questionaire

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of vertigo. Timepoint: The beging of study 30 minutes after drug's prescription. Method of measurement: The visual and verbal questionair.

Secondary

MeasureTime frame
Vomiting ,ataxia , nystagmus. Timepoint: The begining of study 30 minutes after intaking medicine. Method of measurement: The visual and verbal questionair.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Seyed Ashkan Tabibzadeh

Hormozgan university medical sciences

ashkantz@yahoo.com+98 76 3333 4700

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026